Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPLETE T2D: ILPS vs Detemir in Type 2 Diabetes
NCT00494013Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2007
- Primary completion
- Sep 2008
- Countries
- 9
01
Overview
A Phase 3 trial of insulin lispro protamine in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Aug 2007; status: completed.
02
Drugs
insulin lispro protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00494013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494013.